Download the Program Here

 Over 100 Chinese hospital leaders, top government officials and healthcare industry executives gathered July 30 and 31, 2011 at the 2nd Annual International Healthcare Leadership (IHL) symposium in Beijing to discuss one of the world’s most challenging public health issues: Multidrug-Resistant Organisms. The conference, designed to create a high level dialogue among key healthcare leaders on the role of Public Health Policy and Healthcare Management, was hosted by David P. ROYE, Jr., MD, CEO of IHL. The conference was co-organized by China Hospital CEO Magazine, Columbia Global Centers/East Asia-Beijing and Pricewaterhouse Coopers, and was sponsored by Merck and Pricewaterhouse Coopers.

Dr. ROYE described to speakers and guests that the IHL symposium was one of the non-profit organization’s initiatives to provide opportunities for healthcare leaders to exchange ideas, strategies and best practices. “As we face common concerns in our respective healthcare systems, we can share evidence-based knowledge across countries to benefit all,” stated Dr. Roye. IHL is focused on advancing the use of public health scientific measures and evaluation tools to improve healthcare policy, infrastructure and hospital management.

See the Full Story Here